Archives

by in
Entry Author Date Location
IBM Gets Emptoris, Nuance Buys Vlingo, & More Boston-Area Deals News 12/21/11 Boston
Vertex, Ariad, Alnylam, & More Boston-Area Life Sciences Newsmakers 12/16/11 Boston
Third Rock Looks to Fight Fat in a New Way, With Ember Therapeutics 12/15/11 Boston
Ember Therapeutics Garners $34,000,000 Series A Funding 12/15/11 Boston
Allena Kicks Off With $15M, Security Firms Ink Funding, TeraDiode Takes In $10M, & More Boston-Area Deals News 11/23/11 Boston
Aileron Expands Roche Deal, Agios Gets $78M, Genzyme MS Drug Advances, & More Boston-Area Life Sciences News 11/18/11 Boston
Agios Nabs $78M From Partner Celgene, Existing VCs, and Public Funds 11/17/11 Boston
Allena Pharmaceuticals Receives $15,000,000 Series A Round 11/17/11 Boston
Agios Pharmaceuticals Obtains $78,000,000 Series C Round 11/17/11 Boston
Allena Pharma Launches With $15M From Third Rock and Other Top-Tier VCs 11/16/11 Boston
Rhythm Adds Former Merck VP as CEO 11/09/11 Boston
MPM-Backed Rhythm Advances Drug Programs in Diabetes and Obesity 10/25/11 Boston
Biotech VCs Have a Problem, and it Will Get Worse Before It Gets Better 10/24/11 National
This Week’s Xconomy Report on WGBH: Security Innovation, Vertex, West Coast Acquisitions, & More 10/21/11 Boston
Third Rock Launches Sage, Glaxo Malaria Vaccine Relies on Agenus Technology, Vertex Seeks Approval of Cystic Fibrosis Drug, & More Boston-Area Life Sciences News 10/21/11 Boston
Kleiner Perkins, Google Ventures Join Expanded $33.5M Round for Foundation Medicine 10/18/11 Boston
Third Rock Launches Sage Therapeutics with $35M Series A and Plan to Tackle Brain Diseases 10/18/11 Boston
SAGE Therapeutics Obtains $35,000,000 Series A Funding 10/18/11 Boston
TOPICA Pharmaceuticals Receives $27,000,000 Series B Financing 10/18/11 San Francisco
Boston Xconomists and Area Innovators Gather for Special Xconomy Event: The Photos 10/13/11 Boston
Agios and Celgene: Anatomy of an Ultra-Valuable Biotech Marriage 10/11/11 Boston
Agios Pulls in $20M From Celgene, Under Extended Cancer Metabolism Partnership 10/05/11 Boston
Eleven Biotherapeutics Dials Up New CEO, Primes Lead Eye Drug for Clinic Next Year 09/22/11 Boston
Sabet and Wilson Out at Twitter, Hirshland Out at Polaris, & More VC Comings and Goings 09/22/11 Boston
Compuware Scoops Up DynaTrace, Medtronic Buys Salient Surgical, Avedro Snaps Up $25M, & More Boston-Area Deals News 07/13/11 Boston
The Missing Ingredient in Today’s Biotech: Guts 07/11/11 National
Rib-X Inks Sanofi Deal, Zafgen Gets $33M Series C, Allegro Adds $5.4M, & More Boston-Area Life Sciences News 07/08/11 Boston
Zafgen Pockets $33M To Take Obesity Drug Through Next Big Step in Clinical Trials 07/07/11 Boston
Zafgen Lands $33,000,000 Series C Round 07/07/11 Boston
Acetylon Adds $27M, Third Rock Leads Lotus Round, InfraReDx Gets $24M, & More Boston-Area Life Sciences News 07/01/11 Boston
Page 4 of 9 « previous page · next page »